[1] Kazakos K, Lyras DN, Verettas D, Tilkeridis K, Tryfonidis M. The use of autologous PRP gel as an aid in the management of acute trauma wounds. Injury. 2009; 40(8): 801–805; Sánchez M, Delgado D, Sánchez P, Anitua E, Padilla S. Plasma rich in growth factors for the treatment of skeletal muscle injury. In Muscle Injuries in Sport Athletes (pp. 451–464). Switzerland: Springer International Publishing, 2017; A Hamid MS, Mohamede Ali MR, Yusof A, George J, Lee LP. Platelet-rich plasma injections for the treatment of hamstring injuries: A randomized controlled trial. American Journal of Sports Medicine. 2014 Oct; 42(10): 2410–2418.
[2] Kon E, Filardo G, Di Matteo B, Marcacci M. The role of platelet-rich plasma in cartilage repair. In Cartilage (pp. 127–138). Switzerland: Springer International Publishing, 2017.
[3] Marx R, Kevy S, Jacobson M. Platelet rich plasma (PRP): A primer. Practical Pain Management. 2008; 8(2); Foster TE, Puskas BL, Mandelbaum BR, Gerhardt MB, Rodeo SA. Platelet-rich plasma: From basic science to clinical applications. American Journal of Sports Medicine. 2009; 37(11): 2259–2272.
[4] Hall M, Bank P, Meislin R, Jazrawi L, Cardone D. Platelet-rich plasma: current concepts and application in sports medicine. Journal of the American Academy of Orthopaedic Surgeons. 2009; 27: 602–608.
[5] NIH National Library of Medicine, National Center for Biotechnology Information, search for “platelet-rich plasma” [cited 2022 March 12] https://pubmed.ncbi.nlm.nih.gov/?term=Platelet-rich+plasma
[6] Google Scholar, search for “platelet rich plasma” [cited 2022 March 12] https://scholar.google.com/scholar?q=Platelet+rich+plasma&btnG=&hl=en&as_sdt=0%2C5.
[7] Yuan T, Zhang CQ, Wang JHC. Augmenting tendon and ligament repair with platelet-rich plasma (PRP). Muscles, Ligaments and Tendons Journal. 2013; 3(3): 139–149; Hall M, Band P, Meislin R, Jazrawi L, Cardone D. Platelet-rich plasma: Current concepts and application in sports medicine. Journal of the American Academy of Orthopaedic Surgeons. 2009; 17: 602–608; Deal JB, Smith E, Heard W, O’Brien MJ, Savoie III FH. Platelet-rich plasma for primary treatment of partial ulnar collateral ligament tears: MRI correlation with results. Orthopaedic Journal of Sports Medicine. 2017 Nov 8; 5(11).
[8] Fitzpatrick J, Bulsara M, Zheng MH. 2017. The effectiveness of platelet-rich plasma in the treatment of tendinopathy: A meta-analysis of randomized controlled clinical trials. American Journal of Sports Medicine. 2017; 45(1): 226–233; Balasubramaniam U, Dissanayake R, Annabell L. Efficacy of platelet-rich plasma injections in pain associated with chronic tendinopathy: a systematic review. Physician and Sportsmedicine. 2015; 43(3): 253–261.
[9] Sanchez M, Anitua E, Azofra J, Aguirre JJ, Andia I. Intra-articular injection of an autologous preparation rich in growth factors for the treatment of knee OA: A retrospective cohort study. Clinical and Experimental Rheumatology. 2008; 26(5): 910–913; Raeissadat SA, Rayegani SM, Hassanabadi H, Fathi M, Ghorbani E, Babaee M, Azma K. Knee osteoarthritis injection choices: Platelet-rich plasma (PRP) versus hyaluronic acid (a one-year randomized clinical trial). Clinical Medicine Insights: Arthritis and Musculoskeletal Disorders. 2015; 8: 1–8; Andia I, Maffulli N. Platelet-rich plasma for managing pain and inflammation in osteoarthritis. Nature Reviews Rheumatology. 2013; 9(12): 721–730; Sanchez M, Guadilla J, Fiz N, Andia I. Ultrasound-guided platelet-rich plasma injections for the treatment of osteoarthritis of the hip. Rheumatology. 2012; 41: 144–150.
[10] Blanke F, Vavken P, Haenle M, von Wehren L, Pagenstert G, Majewski M. Percutaneous injections of platelet rich plasma for treatment of intrasubstance meniscal lesions. Muscles, Ligaments and Tendons Journal. 2015; 5(3): 162; Wei LC, Gao SG, Xu M, Jiang W, Tian J, Lei GH. A novel hypothesis: The application of platelet-rich plasma can promote the clinical healing of white-white meniscal tears. Medical Science Monitor. 2012; 18(8): HY47–HY50; Hauser RA, Phillips HJ, Maddela H. PRP prolotherapy as first line treatment for meniscal pathology. Practical Pain Management. 2010; 53–63; Braun HJ, Wasterlain AS, Dragoo JL. The use of PRP in ligament and meniscal healing. Sports Medicine and Arthroscopy Review. 2013; 21(4): 206–212.
[11] Moussa M, Lajeunesse D, Hilal G, Atat OE, Haykal G, Serhal R, Chalhoub A, Khalil C, Alaaeddine N. Platelet rich plasma (PRP) induces chondroprotection via increasing autophagy, anti-inflammatory markers, and decreasing apoptosis in human osteoarthritic cartilage. Experimental Cell Research. 2017; 352(1): 146–156; Kon E, Buda R, Filardo G, Di Martino A, Timoncicni A, Cenacchi A, Fornasari PM, Giannini S, Marcacco M. Platelet-rich plasma: Intra-articular knee injections produced favorable results on degenerative cartilage lesions. Knee Surgery, Sports Traumatology, Arthroscopy. 2010; 18(4): 472–479; Vannini F, Di Matteo B, Filardo G. Platelet-rich plasma to treat ankle cartilage pathology from translational potential to clinical evidence: A systematic review. Journal of Experimental Orthopaedics. 2015 Dec 14; 2(1): 2.
[12] Gosens T, Peerbooms JC, Van Laar W, den Oudsten BL. Ongoing positive effect of platelet-rich plasma versus corticosteroid injection in lateral epicondylitis: A double-blind randomized controlled trial with 2-year follow-up. American Journal of Sports Medicine. 2011; 39(6): 1200–1208.
[13] Mishra A, Harmon K, Woodall J, Vieira A. Sports medicine applications of platelet rich plasma. Current Pharmaceutical Biotechnology. 2012; 13: 1185–1195.
[14] Hammond J, Hinton R, Curl LA, Muriel JM, Lovering RM. Use of autologous platelet-rich plasma to treat muscle strain injuries. American Journal of Sports Medicine. 2009; 37(6): 1135–1142.
[15] Sanchez M, Anitua E, Andia I. Application of autologous growth factors on skeletal muscle healing. Poster Presentation at the 2nd World Conference on Regenerative Medicine. Leipzig, Germany; May 18–20, 2005.
[16] Filardo G, Kon E, Della Villa S, Vincentelli F, Maria Fornasari P, Marcacci M. Use of platelet-rich plasma for the treatment of refractory jumper’s knee. International Orthopaedics. 2010; 34(6): 909–915.
[17] Boesen AP, Hansen R, Boesen MI, Malliaras P, Langberg H. Effect of high-volume injection, platelet-rich plasma, and sham treatment in chronic midportion Achilles tendinopathy: A randomized double-blind prospective study. American Journal of Sports Medicine (2017): Di Matteo B, Filardo G, Kon E, Marcacci M. Platelet-rich plasma: Evidence for the treatment of patellar and Achilles tendinopathy—a systematic review. Musculoskeletal Surgery. 2015; 99(1): 1–9.
[18] Muralidharagopalan NR, Loganathan D, Iyer KMJ, Boopathikumar KK. Functional outcomes of platelet rich plasma injections in plantar fasciitis. International Journal of Research in Orthopaedics; 2017 Jul 3; (4): 734–737; Barrett S, Erredge S. Growth factors for chronic plantar fasciitis? Podiatry Today. 2004; 17(11): 35–42; Kumar V, Millar T, Murphy PN, Clough T. The treatment of intractable plantar fasciitis with platelet-rich plasma injection. The Foot. 2013 Sep 30; 23(2): 74–77.
[19] Hanci M, Karamese M, Tosun Z, Aktan TM, Suman S, Savaci N. Intra-articular platelet-rich plasma injection for the treatment of temporomandibular disorders and a comparison with arthrocentesis. Journal of Cranio-Maxillofacial Surgery. 2015; 43(1): 162–166; Hegab AF, Ali HE, Elmasry M, Khallaf MG. Platelet-rich plasma injection as an effective treatment for temporomandibular joint osteoarthritis. Journal of Oral and Maxillofacial Surgery. 2015; 73(9): 1706–1713.
[20] Cameron JA, Thielen KM. Autologous platelet rich plasma for neck and lower back pain secondary to spinal disc herniation: Midterm results. Spine Research. 2017 Aug 30; 3(2): Article ID 100030: 5 pages; Lutz GE. Increased nuclear T2 signal intensity and improved function and pain in a patient one year after an intradiscal platelet–rich plasma injection. Pain Medicine. 2017; 18 (6), 1197–1199; Wang SZ, Chang Q, Lu J, Wang C. Growth factors and platelet-rich plasma: Promising biological strategies for early intervertebral disc degeneration. International Orthopaedics. 2015; 39(5): 927–934; Bhatia R, Chopra G. Efficacy of Platelet Rich Plasma via Lumbar Epidural Route in Chronic Prolapsed Intervertebral Disc Patients-A Pilot Study. Journal of Clinical and Diagnostic Research. 2016 Sep; 10(9): UC05–UC07.
[21] Ko GD, Mindra S, Lawson GE, Whitmore S, Arseneau L. Case series of ultrasound-guided platelet-rich plasma injections for sacroiliac joint dysfunction. Journal of Back and Musculoskeletal Rehabilitation. 2017 Mar 2: 30(2): 363–370.
[22] Sánchez M, Guadilla J, Fiz N, Andia I. Ultrasound-guided platelet-rich plasma injections for the treatment of osteoarthritis of the hip. Rheumatology. 2011 Nov 9; 51(1): 144–150; Dallari D, Stagni C, Rani N, Sabbioni G, Pelotti P, Torricelli P, Tschon M, Giavaresi G. Ultrasound-guided injection of platelet-rich plasma and hyaluronic acid, separately and in combination, for hip osteoarthritis: Dallari D, Stagni C, Rani N, Sabbioni G, Pelotti P, Torricelli P, Tschon M, Giavaresi G. Ultrasound-guided injection of platelet-rich plasma and hyaluronic acid, separately and in combination, for hip osteoarthritis: a randomized controlled study. The American journal of sports medicine. 2016 Mar;44(3):664-71.
[23] Wu J, Zhou J, Liu C, Zhang J, Xiong W, Lv Y, Liu R, Wang R, Du Z, Zhang G, Liu Q. A prospective study comparing platelet-rich plasma and local anesthetic (LA)/corticosteroid in intra-articular injection for the treatment of lumbar facet joint syndrome. Pain Practice. 2017; 17(7): 914–924; Ko GD, Mindra S, Lawson GE, Whitmore S, Arseneau L. Case series of ultrasound-guided platelet-rich plasma injections for sacroiliac joint dysfunction. Journal of Back and Musculoskeletal Rehabilitation. 2017; 30(2): 363–370; Aufiero D. Vincent H, Sampson S, Bodor M. Regenerative injection treatment in the spine: review and case series with platelet rich plasma. Journal of Stem Cell Research, Reviews and Reports. 2015; 2(1): 1019.
[24] Tolbert G. Roy D, Walker V. Ultrasound guided dextrose prolotherapy and platelet rich plasma therapy in chronic low back pain: three case reports. International Journal of Physical Medicine & Rehabilitation; 2013; 1: 149
[25] Gumina S. PRP in rotator cuff healing. In Rotator Cuff Tear (pp. 357–360). Switzerland: Springer International Publishing, 2017; Barker SL, Bell SN, Connell D, Coghlan JA. Ultrasound-guided platelet-rich plasma injection for distal biceps tendinopathy. Shoulder & Elbow. 2015; 7(2): 110–114; Scarpone M, Rabago D, Snell E, DeMeo P, Ruppert K, Pritchard P, Arbogast G, Wilson JJ, Balzono JF. PRP as a treatment alternative for symptomatic rotator cuff tendinopathy for patients failing conservative treatments. Techniques in Orthopaedics. 2007; 22(1): 26–33; Alderman DD. Platelet rich plasma for rotator cuff tears. Practical Pain Management. 2012 September: 21–23.
[26] Papalia R, Zampogna B, Vadala G, Di Martino A, Nobile C. Are platelet rich plasma injections more effective in tendinopathy or enthesopathy. Journal of Pain & Relief. 2017; 6(3): Article ID 1000288, 5 pages; Cohn CS, Lockhart E, McCullough JJ. The use of autologous platelet-rich plasma in the orthopedic setting. Transfusion. 2015; 55(7): 1812–1820; Kovacevic D, Bedi A, Dines JS, Athwal GS. Upper extremity: biologics in treating shoulder disease. Current Orthopaedic Practice. 2015; 26(2): 90–98.
[27] Salamanna F, Veronesi F, Maglio M, Della Bella E, Sartori M, Fini M. New and emerging strategies in platelet-rich plasma application in musculoskeletal regenerative procedures: general overview on still open questions and outlook. BioMed Research International. 2015: Article ID 846045, 24 pages.
[28] Jo CH, Shin JS, Shin WH, Lee SY, Yoon KS, Shin S. Platelet-rich plasma for arthroscopic repair of medium to large rotator cuff tears: a randomized controlled trial. American Journal of Sports Medicine. 2015; 43(9): 2102–2110; Sanchez M, Anuita E, Azofra J, Andia I, Padilla S, Mujika I. Comparison of surgically repaired Achilles tendon tears using platelet-rich fibrin matrices. The American Journal of Sports Medicine. 2007; 25(2): 245–251.
[29] Foster T, Puskas B, Mandelbaum BR, Gerhardt MB, Rodeao SA. Platelet-rich plasma: From basic science to clinical applications. American Journal of Sports Medicine. 2009; 37(11): 2259–2272.
[30] Garg, A. “The use of platelet rich plasma to enhance the success of bone grafts around dental implants.” Dental Implantology Update. 2000; 11(3):17–21.
[31] Alexander R, Abuzeni P. Enhancement of autologous fat transplantation with platelet rich plasma. American Journal of Cosmetic Surgery. 2001; 18: 59–70.
[32] Kazakos K, Lyras DN, Verettas D, Tilkeridis K, Tryfonidis M. The use of autologous PRP gel as an aid in the management of acute trauma wounds. Injury. 2009; 40(8): 801–805.
[33] Mishra A, Pavelko T. Treatment of chronic elbow tendinosis with buffered platelet-rich plasma. American Journal of Sports Medicine. 2006; 34(11): 1774–1778.
[34] Schwartz, A. A Promising Treatment for Athletes, in Blood. The New York Times, Feb 16, 2009. [cited 2022 March 12] https://www.nytimes.com/2009/02/17/sports/17blood.html
[35] Tendon Trouble: New treatment uses enhanced plasma. Mayo Clinic Health Letter. 2010 March, p. 7.
[36] FOXSPORTS, Stephen Curry’s ‘PRP’ knee therapy, explained. May 4, 2016 [cited 2022 March 12] https://www.foxsports.com/stories/nba/stephen-currys-prp-knee-therapy-explained
[37] Marx R, Garg A. Dental and Craniofacial Applications of Platelet-Rich Plasma. Hanover, Illinois: Quintessence Publishing Co., Inc. 2005.
[38] Langer HE, Stellos K, Steingen C, Froihofer A, Schonberger T, Kramer B, Bigalke B, May AE, Seizer P, Muller I, Gieseke F, Siegel-Axel D, Meuth SG, Schmidt A, Wendel HP, Bloch W, Gawaz M, Muller I. Platelet derived bFGF mediates vascular integrative mechanisms of mesenchymal stem cells in vitro. Journal of Molecular and Cellular Cardiology. 2009; 47(2): 315–325; Lyras D, Kazakos K, Verettas D, Botaitis S, Agrogiannis G, Kokka A, Pitiakoudis M, Kotzakaris A. The effect of platelet-rich plasma gel in the early phase of patellar tendon healing. Archives of Orthopaedic and Trauma Surgery. 2009; 129: 1577–1582.
[39] Kakudo N, Morimoto N, Kushida S, Ogawa T, Kusumoto K. Platelet-rich plasma releasate promotes angiogenesis in vitro and in vivo. Medical Molecular Morphology. 2014; 47(2): 83–89; Lyras DN, Kazakos K, Verettas D, Polychronidis A, Tryfonidis M, Botaitis S, Agrogiannis G, Simopoulos C, Kokka A, Patsouris E. The influence of platelet-rich plasma on angiogenesis during the early phase of tendon healing. Foot & Ankle International. 2009 Nov; 30(11): 1101–1106.
[40] Hayneswoth SE, Kadiyala S, Liang LN, Thomas T, Bruder SP. Chemotactic and mitogenic stimulation of human mesenchymal stem cells by platelet rich plasma suggests a mechanism for enhancement of bone repair. Presented at the 48th Annual Meeting of the Orthopaedic Research Society, Dallas, Texas; February 10–13, 2002 www.perstat.com/ortho1.pdf; Haynesworth SE, Bruder SP. Mitogenic stimulation of human mesenchymal stem cells by platelet releasate. Poster Presentation, American Academy of Orthopedic Surgery. 2001 March.
[41] Fitzpatrick J, Bulsara MK, McCrory PR, Richardson M.D., Zheng MH. Analysis of platelet-rich plasma extraction: Variations in platelet and blood components between 4 common commercial kits. Orthopaedic Journal of Sports Medicine. 2017; 5(1).
[42] Marx R. Platelet-rich plasma: Evidence to support its use. Journal of Oral and Maxillofacial Surgery. 2004; 62: 489–496; Haynesworth SE, Kadiyala S, Liang LN, Thomas T, Bruder SP. Chemotactic and mitogenic stimulation of human mesenchymal stem cells by platelet rich plasma suggests a mechanism for enhancement of bone repair. Presented at the 48th Annual Meeting of the Orthopaedic Research Society, Dallas, Texas; February 10–13, 2002. www. perstat.com/ortho1.pdf; Lansdown DA, Fortier LA. Platelet-rich plasma: formulations, preparations, constituents, and their effects. Operative Techniques in Sports Medicine. 2017; 25(1): 7–12.
[43] Weibrich G, Hansen T, Kleis W, Buch R, Hitzler WE. Effect of platelet concentration in platelet-rich plasma on peri-implant bone regeneration. Bone. 2004; 34(3): 665–671.
[44] Boswell SG, Schnabel LV, Mohammed HO, Sundman EA, Minas T, Fortier LA. Increasing platelet concentrations in leukocyte-reduced platelet-rich plasma decrease collagen gene synthesis in tendons. American Journal of Sports Medicine. 2014 Jan; 42(1): 42–49; Giusti I, Rughetti A, D’ascenzo S, Millimaggi D, Pavan A, Dell’Orso L, Dolo V. Identification of an optimal concentration of platelet gel for promoting angiogenesis in human endothelial cells. Transfusion. 2009 Apr 1; 49(4): 771–778.
[45] Dhillon MS, Patel S, John R. PRP in OA knee–update, current confusions and future options. SICOT-J. 2017; 3: 27.
[46] Filardo G, Kon E, Di Matteo B, Di Martino A, Sessa A, Letizia Merli M, Marcacci M. Leukocyte-poor PRP application for the treatment of knee osteoarthritis. Joints. 2013; 1(3): 112–120.
[47] Kawazoe T, Kim HH. Tissue augmentation by white blood cell-containing platelet-rich plasma. Cell Transplantation. 2012; 21(2–3): 601–607; Bielecki T, Dohan-Ehrenfest DM, Everts PA, Wiczkowski A. The role of leukocytes from L-PRP/L-PRF in wound healing and immune defense: New perspectives. Current Pharmaceutical Biotechnology. 2012; 13(7): 1153–1162.
[48] Weglein A, Sampson S, Aufiero D. Platelet rich plasma practical use in non-surgical musculoskeletal pathology. In Platelet Rich Plasma: Lecture Notes in Bioengineering (pp. 187–201). Berlin, Germany: Springer-Verlag, 2014.
[49] Alsousou J, Thompson M, Hulley P, Noble A, Willett K. The biology of platelet-rich plasma and its application in trauma and orthopaedic surgery. Journal of Bone and Joint Surgery (British Volume). 2009; 91(8): 987–996.
[50] Fufa D, Shealy B, Jacobson M, Kevy S, Murray MM. Activation of platelet-rich plasma using soluble type I collagen. Journal of Oral and Maxillofacial Surgery. 2008; 66(4): 684–690; Hall M. Band P, Meislin R, Jazrawi L, Cardone D. Platelet-rich plasma: Current concepts and application in sports medicine. Journal of the American Academy of Orthopaedic Surgeons. 2009; 17(10): 602–608.
[51] Wu J, Zhou J, Liu C, Zhang J, Xiong W, Lv Y, Liu R, Wang R, Du Z, Zhang G, Liu Q. A prospective study comparing platelet-rich plasma and local anesthetic(LA)/corticosteroid in intra-articular injection for the treatment of lumbar facet joint. Pain Practice. 2017; 17(7): 914–924; Mundla GKR, Venkataramana PK, Koduru MKR, Ravindran B. Study comparing the efficacy of platelet rich plasma versus steroid versus placebo in lateral epicondylitis. International Journal of Research in Orthopaedics. 2017; 3(2): 207–212; Nasser MET, El Yasaki AZ, El Mallah RME, Abdelazeem ASM. Treatment of lateral epicondylitis with platelet-rich plasma, glucocorticoid, or saline. A comparative study. Egyptian Rheumatology and Rehabilitation. 2017; 44(1): 1.
[52] Gosens T, Peerbooms JC, van Laar W, den Oudsten BL. Ongoing positive effect of platelet-rich plasma versus corticosteroid injection in lateral epicondylitis: A double-blind randomized controlled trial with 2-year follow-up. The American Journal of Sports Medicine. 2011; 39(6): 1200–1208.
[53] MiB,LiuG,ZhouW,LvH,LiuY,WuQ,LiuJ.Plateletrich plasma versus steroid on lateral epicondylitis: meta-analysis of randomized clinical trials. The Physician and Sportsmedicine. 2017; 45(2): 97–104.
[54] Monto RR. Platelet-rich plasma efficacy versus corticosteroid injection treatment for chronic severe plantar fasciitis. Foot & Ankle International. 2014; 35(4): 313–318.
[55] Wu J, Zhou J, Liu C, Zhang J, Xiong W, Lv Y, Liu R, Wang R, Du Z, Zhang G, Liu Q. A prospective study comparing platelet-rich plasma and local anesthetic(LA)/corticosteroid in intra-articular injection for the treatment of lumbar facet joint. Pain Practice. 2017; 17(7): 914–924.
[56] Moussa M, Lajeunesse D, Hilal G, El Atat O, Haykal G, Serhal R, Chalhoub A, Khalil C, and Alaaeddine N. Platelet rich plasma (PRP) induces chondroprotection via increasing autophagy, anti-inflammatory markers, and decreasing apoptosis in human osteoarthritic cartilage. Experimental Cell Research. 2017; 352(1): 146–156; Xie, X, Ulici V, Alexander P, Jiang Y, Zhang C, Tuan RS. Platelet-rich plasma inhibits mechanically induced injury in chondrocytes. Arthroscopy: The Journal of Arthroscopic and Related Surgery. 2015 Jun; 31(6): 1142–1150; Gato-Calvo L, Vela-Anero A, Loures-Fraga E, Ruiz Romero C, Blanco FJ, Burguera EF. Proliferative and anti-inflammatory effect of platelet-rich plasma on osteoarthritic chondrocytes. Osteoarthritis and Cartilage. 2017; 25: S270–S271.
[57] Creaney L, Hamilton B. Growth factor delivery methods in the management of sports injuries: The state of play. British Journal of Sports Medicine. 2008; 42(5): 314–320.
[58] Marx R. The biology of platelet-rich plasma (reply to letter to the editor). Journal of Oral and Maxillofacial Surgery. 2001; 59: 1120.
[59] Schmitz JP, Hollinger J. The biology of platelet-rich plasma (letter to the editor). Journal of Oral and Maxillofacial Surgery. 2001 Sept 30; 59(9): 1119–1120.
[60] Sanchez A, Sheridan P, Kupp L. Is platelet-rich plasma the perfect enhancement factor? A current review. International Journal of Oral & Maxillofacial Implants. 2002; 18: 93–103.
[61] Bielecki T, Gazdik T, Arendt J, Szxzepanski T, Kroi W, Wielkoszynski T. Antibacterial effect of autologous platelet gel enriched with growth factors and other active substances. Journal of Bone and Joint Surgery (British Volume). 2007; 89(3): 417–420.
[62] Clark G. Platelet rich plasma (PRP) therapy literature reviews. Journal of Prolotherapy. August 2009; 1(3): 185–191.